Dr G Ranjith

Dr G Ranjith

Dr G Ranjith

Qualification: MBBS,MD(General medicine),DM(Neurology), FSIN
Specialty: Neurologist
Designation: Consultant Neurologist
Experience: 10 Years
HITEC City

5/5

About Dr G Ranjith

Dr G Ranjith is a Consultant Neurologist at Medicover Hospitals HITEC City.

Expertise:

  • STROKE AND ENDOVASCULAR INTERVENTIONS
  • Headache
  • Parkinson’s Disease
  • Alzheimer’s Disease/ Dementia
  • Movement Disorders
  • Muscle and Nerve disorders
  • BOTOX Injection

Awards & Recognisition:

  • Clinical profile and etiological analysis of new onset epilepsy in adults” won best platform presentation.
  • Persued Post Doctoral Fellowship in Stroke and Intervention Neurology after DM.

Publications:

  • Co Author of text book chapter, “Vasculitis in stroke” published in IAN 2019 update.
  • Co Author of “Socioeconomic consequences of drug-resistant epilepsy in an adult cohort from southern India” published in Epilepsy and Behavior journal.
  • “Diagnostic correlation of sural nerve histopathology with clinical and electrophysiological findings in peripheral nerve diseases” done under guidance of Dr.S.P.Gorthi, which was presented in Super EMG conference, Trivandrum, Kerala 2018.
  • “Analysis of etiology and functional outcomes of inflammatory demyelinating diseases” done under the guidance of Prof.Dr.S.P.Gorthi, Platform presentation in IANCON 2018, Raipur.
  • “Angiographic characters in lacunar stroke” done under guidance of Prof.Dr.S.P.Gorthi and was presented as poster in Indian national stroke conference, Ahmedabad, 2019.
  • “Clinical and radiological profile of CNS vasculitis presenting as stroke” done under guidance of Prof.Dr.S.P.Gorthi ; which was presented as poster in Indian national stroke conference, Delhi, 2018.
  • “Endothelial dysfunction in type 2 diabetes” done under guidance of Prof.Dr.P.Gandiah, which was presented as poster in 2015 , APICON.
  • “Diastolic dysfunction in normotensives” done under guidance of Prof.Dr.P.Gandiah, which was presented in 2016 , APICON.

Covid-19: All you need to know.